Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
The research interests of Cheryl E. Myers, Ph.D., focus on translational regenerative medicine and the application of safe and effective cellular therapies and bioengineered products that can restore tissue and function. Dr. Myers uses immunological, functional and histological approaches, as well as genomics and proteomics, to characterize the body's response to these regenerative therapies. Dr. Myers leads the Arizona Discovery Translation Application Incubator, which assists clinical investigators in addressing unmet clinical needs.
Regenerative medicine is an innovative field that focuses on the repair, replacement and regeneration of tissues and organs. This is an important approach for individuals with pretransplant malignancy in need of a donor transplant. Currently, the risk of cancer recurrence following the transplant of donor tissue must be weighed against the benefit of the transplant. Regenerative medicine therapies that can prevent the need for donor tissue will both benefit those individuals who are on transplant waitlists and aid patients with cancer in receiving transplants that would otherwise not be feasible.
Regenerative medicine therapies offer hope to patients who previously had ineffective or no treatment options. Individualized patient care and treatments will lead to better health outcomes and quality of life.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.